VAREX IMAGING CORP DL-,01 Logo
US92214X1063
A2DKK2
VREX

VAREX IMAGING CORP DL-,01

Kurser indlæses...

Prognose

Analytikernes gennemsnitlige kursmål er 13,11 € (-21,02 %). Medianen er 13,11 € (-21,02 %).

Køb
  2
Behold
  5
Sælg
  0

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • Varex Imaging expects earnings jump in quarterly report on 10 August 2026

    Varex Imaging will release results for the most recent quarter on 10 August 2026. Analysts on average expect an EPS of 0.21 USD (prior year: -2.15 USD) and revenue of 215.5 million USD (prior year: 203.0 million USD). For the current fiscal year, analysts forecast on average an EPS of 0.907 USD and revenue of 871.0 million USD (prior year: 844.6 million USD). » Mere på finanzen.net


  • Varex Imaging beats Q2 EPS expectations, gross margin falls and stock drops after hours

    Varex Imaging reported Q2 fiscal 2026 EPS of $0.21 on revenue of $216 million, both slightly above forecasts. Non-GAAP gross margin fell to 34% (down 240 basis points), mainly due to higher raw material costs, while operating expenses increased. The stock fell 2.79% to $11.99 in after-hours trading, despite planned investments in AI-enabled imaging and photon-counting technology. The company sees EPS of $0.23 for Q3 and $0.30 for Q4. » Mere på de.investing.com


  • Varex Imaging sees steady demand, tariff relief and India ramp to lift margins

    Varex Management says recent geopolitical events have not materially affected demand, with healthcare stable and security inquiries flat to positive. The company expects modest gross-margin improvement of roughly 30–50 basis points as higher-tariff inventory clears and is pursuing supply-chain diversification and local manufacturing. Growth and profitability levers include an India manufacturing ramp targeting about $100 million of incremental radiographic revenue over ~two years, expansion in photon-counting CT and cargo-inspection businesses, and a debt refinancing that should save about $7–8 million annually (~$0.15–$0.16 EPS). » Mere på finance.yahoo.com


  • Varex Imaging outlines growth plans with photon-counting and expansion in India

    At the Sidoti Small‑Cap Conference, Varex Imaging presented its strategy: growth will be driven by photon‑counting technology, increased production in India and strong demand for cargo inspection systems. The company passed on customs costs to customers, significantly reduced the coupon on its debt from 7.875% to about 6% and paid down debt, increasing financial flexibility. Production in India is up and running but not yet at full capacity; x‑ray tube manufacturing is expected to be completed by year‑end, with revenues anticipated from 2027. The first photon‑counting customer system is planned for early 2027 and is likely to materially boost free cash flow together with completed plants. Political uncertainty and volatile conditions remain key risks. » Mere på de.investing.com


  • Varex Imaging outlines growth and cost-cutting plan at Oppenheimer conference

    Varex Imaging presented a strategic overview and emphasized resilience to geopolitical tensions and tariff changes. The company expects a slight improvement in gross margin from reduced tariffs and anticipates around $100 million in incremental revenue from its India site by fiscal 2027. Varex is advancing photon-counting technology and aims to partner with at least three OEMs by 2028. A debt refinancing reduces interest costs and saves $7–8 million annually; direct operational impacts from the geopolitical situation are considered minimal. » Mere på de.investing.com

Virksomhedstal

I det seneste kvartal havde VAREX IMAGING CORP DL-,01 en omsætning på 183,96 mio. € og et nettoresultat på 13,72 mio. €
(EUR) juli 2026
YoY
Omsætning 183,96 mio. 6,74 %
Bruttofortjeneste 67,03 mio. 16,97 %
Nettoresultat 13,72 mio. 118,14 %
EBITDA 25,34 mio. 141,99 %

Fundamentale data

Nøgletal Værdi
Markedsværdi
705,96 mio. €
Antal aktier
42,46 mio.
Højeste/laveste i 52 uger
16,84 € - 8,22 €
Udbytte Nej
Beta
1,03
P/E (PE Ratio)
35,03
PEG (PEG Ratio)
0,21
K/I (PB Ratio)
1,56
P/S (PS Ratio)
0,90

Virksomhedsprofil

Varex Imaging Corporation designer og fremstiller komponenter til røntgenbilleddannelse. Virksomheden er organiseret i to segmenter, Medical og Industrial. Medical-segmentet designer, fremstiller, sælger og servicerer komponenter til røntgenbilleddannelse, herunder røntgenrør, digitale detektorer, højspændingsstik, software og arbejdsstationer til billedbehandling, software til 3D-rekonstruktion og computerassisteret diagnostik, kollimatorer, enheder til automatisk eksponeringskontrol, generatorer, varmevekslere, ioniseringskamre og buckys. Segmentets produkter anvendes i en række applikationer, herunder radiografisk og fluoroskopisk billedbehandling, mammografi, computertomografi, strålebehandling, onkologi, CT, kardiologi, kirurgi, odontologi, computerassisteret detektion og andre diagnostiske radiografiske anvendelser. Industrial-segmentet designer, fremstiller, sælger og servicerer Linatron-røntgenacceleratorer, røntgenrør, digitale detektorer og højspændingsstik til brug i sikkerheds- og industrielle inspektionsapplikationer, såsom lufthavnssikkerhed, scanning af last i havne og ved grænser samt ikke-destruktiv prøvning og undersøgelse i forskellige applikationer. Varex Imaging Corporation sælger sine produkter gennem originale udstyrsproducenter af billeddannelsessystemer, uafhængige serviceselskaber og distributører samt direkte til slutbrugere. Virksomheden har aktiviteter i Nordamerika, Sydamerika, Europa, Rusland, Mellemøsten, Indien, Afrika, Asien og Australien. Varex Imaging Corporation blev grundlagt i 2016 og har hovedkontor i Salt Lake City, Utah.

Navn
VAREX IMAGING CORP DL-,01
CEO
Sunny S. Sanyal
Hjemsted Salt Lake City, ut
USA
Websted
Sektor
Sundhed
Branche
Sundhedsteknologi
Børsnotering
23.01.2017
Medarbejdere 2.500

Tickersymboler

Børs Symbol
NASDAQ
VREX
Frankfurt
VI4.F
Düsseldorf
VI4.DU
SIX
VI4.SW
München
VI4.MU
🍪

Parqet  bruger cookies. Læs mere